Literature DB >> 31571100

Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia.

Liansheng Zhao1,2, Huijuan Wang3, Yamin Zhang1,2, Jinxue Wei1,2, Peiyan Ni1,2, Hongyan Ren1,2, Gang Li4, Qiang Wang1,2, Gavin P Reynolds5, Weihua Yue6,7, Wei Deng1,2, Hao Yan6,7, Liwen Tan8, Qi Chen9, Guigang Yang10, Tianlan Lu6,7, Lifang Wang6,7, Fuquan Zhang11, Jianli Yang12,13, Keqing Li14, Luxian Lv15, Qingrong Tan16, Yinfei Li1,2, Hua Yu1,2, Hongyan Zhang6,7, Xin Ma9, Fude Yang10, Lingjiang Li8, Chuanyue Wang9, Huiyao Wang1,2, Xiaojing Li1,2, Wanjun Guo1,2, Xun Hu17, Yang Tian1,2, Xiaohong Ma1,2, Jeremy Coid1,2, Dai Zhang6,7, Chao Chen18, Tao Li19,20.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31571100      PMCID： PMC6864018          DOI： 10.1007/s12264-019-00432-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  16 in total

1.  5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.

Authors:  Magali Noro; Irina Antonijevic; Carlos Forray; Siegfried Kasper; Neslihan Aygun Kocabas; Yves Lecrubier; Sylvie Linotte; Julien Mendlewicz; Stuart Montgomery; Lenore Snyder; Daniel Souery; Paul Verbanck; Joseph Zohar; Isabelle Massat
Journal:  Int Clin Psychopharmacol       Date:  2010-07       Impact factor: 1.659

2.  Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients.

Authors:  Julia Staeker; Stefan Leucht; Barbara Laika; Werner Steimer
Journal:  Genet Test Mol Biomarkers       Date:  2013-11-05

3.  Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.

Authors:  Pothitos M Pitychoutis; Arnauld Belmer; Imane Moutkine; Joëlle Adrien; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

4.  HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Shinpei Nonen; Shiho Sakai; Naotaka Sunada; Yosuke Koshikawa; Masataka Wakeno; Gaku Okugawa; Toshihiko Kinoshita; Alessandro Serretti
Journal:  J Clin Psychopharmacol       Date:  2015-06       Impact factor: 3.153

5.  Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

Authors:  Francis J McMahon; Silvia Buervenich; Dennis Charney; Robert Lipsky; A John Rush; Alexander F Wilson; Alexa J M Sorant; George J Papanicolaou; Gonzalo Laje; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Husseini Manji
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

6.  Association of MSI2 Gene Polymorphism with Age-at-Onset of Schizophrenia in a Chinese Population.

Authors:  Zhi-Lin Luan; Xiao-Hui Cui; Hu Xu; He-Yuan Lu; Yu-Yuan Li; Tian-Lan Lu; Dai Zhang
Journal:  Neurosci Bull       Date:  2017-09-02       Impact factor: 5.203

7.  D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.

Authors:  Jian-Ping Zhang; Todd Lencz; Anil K Malhotra
Journal:  Am J Psychiatry       Date:  2010-03-01       Impact factor: 18.112

8.  Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population.

Authors:  Xiaofei Ji; Nagahide Takahashi; Shinichi Saito; Ryoko Ishihara; Nobuhisa Maeno; Toshiya Inada; Norio Ozaki
Journal:  Neurosci Lett       Date:  2008-02-16       Impact factor: 3.046

9.  Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1.

Authors:  Matt J Neville; Elaine C Johnstone; Robert T Walton
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

10.  Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.

Authors:  Jian-Yang Lin; Ming-Yan Jiang; Zhou-Mi Kan; Yang Chu
Journal:  J Affect Disord       Date:  2014-07-23       Impact factor: 4.839
View more
  1 in total

Review 1.  Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.

Authors:  Qiongqiong Wu; Xiaoyi Wang; Ying Wang; Yu-Jun Long; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Neurosci Bull       Date:  2021-07-05       Impact factor: 5.203
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.